![Graham Ross](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Graham Ross
Net worth: - $ as of 2025-12-30
Profile
Graham Ross is currently the Chief Medical Officer & Head-Clinical Development at Immix Biopharma, Inc. He previously worked as the Senior Director-Medical Science at AstraZeneca PLC from 2015 to 2017 and as the Director-Clinical Development at GSK Plc from 1995 to 2006.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-04-21 | 0 ( -.--% ) | - $ | 2025-12-30 |
Graham Ross active positions
| Companies | Position | Start |
|---|---|---|
| IMMIX BIOPHARMA, INC. | Chief Tech/Sci/R&D Officer | 2021-05-31 |
Former positions of Graham Ross
| Companies | Position | End |
|---|---|---|
| ASTRAZENECA PLC | Corporate Officer/Principal | 2016-12-31 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 2005-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Manufactures pharmaceutical products | |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Immix Biopharma, Inc.
 Immix Biopharma, Inc. Operates as a biopharmaceutical company that develops therapies for cancer patients |
- Stock Market
- Insiders
- Graham Ross
